Sorry to have been away so long. The blog had over 100 posts before updates stopped but it is back now and hopefully will have 100 more before there’s another break….Today we talk about a doctor who claims he is close to being able to transplant a human head from one person to another. Moral and ethical questions aside, this would be one of the most newsworthy events for a long time. Read more at: http://www.dailymail.co.uk/news/article-3412928/The-real-life-Doctor-Frankenstein-plotting-human-HEAD-transplants-Controversial-neurosurgeon-wants-paralysed-patient-new-body.html
Earlier this year, Colorado-based MicroBiome Therapeutics kicked off a round of funding to finance a drug intended to improve the tolerability of Metformin (also known as Glucophage), a popular diabetes drug with numerous side-effects. If this drug, a reformulation of Metformin know as NM505 , is successful, it will provide relief to the approximately 50% of Metformin patients who experience diarrhea from the drug and the approximately 25% of patients who experience vomiting. Read more at: http://medcitynews.com/2015/04/colorado-startups-microbiome-modulating-drug-improve-metformin-tolerability/?rf=1 or http://www.mbiome.com/.
Livongo Health, which secured $20 million in financing earlier this year to support expansion of it’s connected device, has a “three step” program for managing diabetes. They say that their program ” …fits right into your life. It listens, responds, and adapts to you.” The program is made up of these three pieces: 1) A Connected Device, 2) Smart Cloud, and 3) A Care Team made up of Certified Diabetes Educators. Read More at: http://www.livongo.com/
One way to improve care delivery is by providing communications in the patients’ own language. Geacom, Inc has developed Phraser a rugged, designed-for-healthcare device that is intended to “integrate easily into your practice, enabling you to provide the best experience.” Read more about this award-winning device at: http://www.myphrazer.com/
Zest Health provides a cloud-based platform, mobile apps, concierge services for it’s members. Their goal is to facilitate appointment scheduling, relevant messaging, healthcare shopping, and provide a single application that integrates all the user’s benefits and plans. Read More at: http://www.zesthealth.com/
With the Internet of Things (IoT) expected to grow to around 200 billion by 2020 (according to Intel), it is no surprise that we have started to see inventions like this smart, wireless, pill-bottle from AdhereTech. Designed to improve adherence and to track in real-time. From the company web-site, the pill bottle: “These bottles collect and send all adherence data in real-time. The system automatically analyzes this information and populates the data on our secure dashboard. If doses are missed, patients can receive customizable alerts and interventions – using automated phone calls, text messages, and more.” Read more at: http://adheretech.com/
From the plos.org (Public Library of Science), we hear about trials that will begin for Gene Therapy to try to treat the rare disease GAN ( Giant Axonal Neuropathy) that behaves very similarly to ALS in children. Lori and Matt Sames have raised over $6 million to help fund these trials in an effort to treat their daughter, Hannah, who is afflicted with the disease. Read more at: